Acta Oncologica

Papers
(The median citation count of Acta Oncologica is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–201775
The first decade of the Danish Palliative Care Database: improvements and ongoing challenges in the quality and use of specialised palliative care29
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric features29
Evaluation of in vitro irradiation setup: Designed for the horizontal beamline at the Danish Centre for Particle Therapy26
A study of microRNAs as new prognostic biomarkers in anal cancer patients26
Use of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data24
Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature24
Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study23
Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment22
Malignancy rates of salivary gland tumors in Greenlandic Inuit comparable to non-endemic populations; epidemiological mapping of salivary gland tumors 1990–201922
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact22
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study21
Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: a prospective population-based study21
Socioeconomic inequality in cancer in the Nordic countries. A systematic review20
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study20
Health-Related Quality of Life in Danish Cancer Survivors Referred to a Late Effects Clinic: A Prospective Cohort Study20
Methylphenidate for treating fatigue in palliative cancer care – effect and side effects in real-world data from a palliative care unit20
Hybrid planning techniques for early-stage left-sided breast cancer: dose distribution analysis and estimation of projected secondary cancer-relative risk18
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer17
Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer17
Influence of radiotherapy technique on incidental dose to the whole ventricular system in focal irradiation of nongerminomatous germcell tumours17
Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study17
The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy – the TABANETOC trial: study protocol for a randomized clinical multicenter tri17
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysis17
Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA16
Complications after proton radiotherapy in children, focusing on severe late complications. A complete Swedish cohort 2008–201915
Script-based automatic radiotherapy planning for cervical cancer15
Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes15
Unusual cases of sinonasal malignancies: a letter to the editor on HPV-positive sinonasal squamous cell carcinomas14
Survival benefit of prophylactic cranial irradiation in limited-stage small-cell lung cancer in modern magnetic resonance imaging staging: a systematic review and meta-analysis14
Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer14
Unchanged perfusion in normal-appearing white and grey matter of glioma patients nine months after proton beam irradiation14
When breast cancer comes to the ICU: outcomes and prognostic factors14
Carbon-fiber alternative to the commercial gating surrogate for the Varian Truebeam™14
Splenectomised Hodgkin lymphoma patients: does severe pneumococcal disease pose a problem today and what is the best long-term strategy?14
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial14
Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men14
Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma14
CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research13
Influence of various assumptions for the individual TNM components on the TNM stage using Nordic cancer registry data13
Mandible osteoradionecrosis after high-dose radiation therapy for head and neck cancers: risk factors and dosimetric analysis13
The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP)13
The national incidence of chondrosarcoma of bone; a review13
Evaluation of sex inequity in lung-cancer-specific survival13
The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients: a Danish patterns of care study13
Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer12
Desmoplastic non-infantile ganglioglioma mimicking diffuse leptomeningeal glioneuronal tumor: precision diagnostics and therapeutic implications12
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study12
Statin therapy and anthracycline-related cardiac dysfunction: a meta-analysis of randomized clinical trials12
Factors predicting long-term physical activity of breast cancer survivors. 5-year-follow-up of the BREX exercise intervention study12
Are education and cohabitation associated with health-related quality of life and self-management during breast cancer follow-up? A longitudinal study12
Treatment-related mortality among children with cancer in Denmark during 2001-202112
Proton range uncertainty caused by synthetic computed tomography generated with deep learning from pelvic magnetic resonance imaging12
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy12
The first direct method of spot sparsity optimization for proton arc therapy12
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non–small cell lung cancer12
Treatment patterns, survival, and healthcare utilisation and costs in patients with locally advanced and metastatic bladder cancer in Denmark 2015–202011
Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women11
Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis11
Multi-center comparison between proton and photon plans for mediastinal lymphomas11
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit10
A national repository of complete radiotherapy plans: design, Results, and experiences10
Protontherapy to maintain local control of head and neck paragangliomas10
Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma10
Predictive value of micro-RNA expression profiling in pediatric desmoid fibromatosis10
An experimental setup for proton irradiation of a murine leg model for radiobiological studies10
Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre10
Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals10
Dosimetric effects of respiratory motion during stereotactic body radiation therapy of lung tumors10
Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries10
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study10
Psychobiological stress response to a lung cancer diagnosis: a prospective study of patients in Iceland and Sweden10
Diet and bowel symptoms among colon cancer survivors10
Uncommon metachronous multiple sites recurrences of metastatic osteosarcoma cured by surgery: a case report9
Impact of previous depression on the risk of suicide among prostate cancer patients9
Interventions for work participation of unemployed or work-disabled cancer survivors: a systematic review9
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study9
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers9
Physical and psychological symptom burden in patients and caregivers during follow-up care after curative surgery for cancers in the pancreas, bile ducts or duodenum9
The risk of radiation-induced neurocognitive impairment and the impact of sparing the hippocampus during pediatric proton cranial irradiation9
Cancer in the Faroe Islands from 1960-2019 – incidence, mortality, and comparisons with the other Nordic countries9
Impact of the COVID-19 pandemic on number and stages of tumors – data of a German cancer registry9
Cancer in young adulthood – classifying the intensity of treatment9
A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment9
C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients9
Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma9
Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors9
Impact on Health-Related quality of life after wearing compression garment or not for six months in women with mild breast cancer-related arm lymphedema. A cross-sectional study9
Pilot implementation of MiLES: a web-based intervention targeted at managers with the aim of enhancing the successful return to work of employees with cancer9
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy8
Acute normal tissue responses in a murine model following fractionated irradiation of the head and neck with protons or X-rays8
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors8
Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization8
Classification of laterality and mastectomy/lumpectomy for breast cancer patients for improved performance of deep learning auto segmentation8
The ultimate local failure rate after the watch-and-wait strategy for rectal cancer: a systematic review of literature and meta-analysis8
Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer8
Prospective randomised phase II trial evaluating adjuvant pelvic radiotherapy using either IMRT or 3-Dimensional planning for endometrial cancer8
Perceived burden and need for support among caregivers of cancer patients8
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy8
Patient-centered development ofEmbrace Pain: an online acceptance and commitment therapy intervention for cancer survivors with chronic painful chemotherapy-induced peripheral neuropathy8
High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation7
The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer7
Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial7
Commentary to ‘Incidence of vestibular schwannoma in Finland, 1990–2017’ Pediatric vestibular schwannomas: an overlooked epidemiological aspect?7
The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care7
Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma7
Societal costs of ovarian cancer in a population-based cohort – a cost of illness analysis7
Association of patient-reported pain with survival in bladder cancer: a post-hoc analysis of the iBLAD trial7
Digital solution in the follow-up of early breast cancer a randomized study7
Multimodal prehabilitation in elective oncological colorectal surgery enhances preoperative physical fitness: a single center prospective real-world data analysis7
Referral patterns of GIST patients: data from a nationwide study7
Electron beam radiotherapy for the management of squamous cell carcinoma of the anal margin7
Experimental validation of a novel method of dose accumulation for the rectum7
The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors7
Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study7
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study7
Sexually transmitted diseases in cancer patients diagnosed under the age of 20 years – a national registry-based cohort study from Finland7
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials7
Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characterist7
Hot dots – which nodes should be removed in sentinel lymph node biopsy for melanoma?7
Blood sampling patterns in primary care change several years before a cancer diagnosis6
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms6
Multi-disciplinary team meetings for lung cancer in Norway and Denmark: results from national surveys and observations with MDT-MODe6
Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis6
Transitioning from conventional photon therapy to proton therapy for primary brain tumors6
Somatostatin receptor expression in Merkel cell carcinoma: correlation with clinical data6
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer6
Correction6
Correction6
Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project6
Cluster model incorporating heterogeneous dose distribution of partial parotid irradiation for radiotherapy induced xerostomia prediction with machine learning methods6
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis6
Increased use of computed tomography in Denmark: stage shift toward early stage lung cancer through incidental findings6
Real-world survival of Danish patients with HER2-positive metastatic breast cancer6
Primary splenic angiosarcoma: a case series of a rare oncological entity and diagnostic challenge6
Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia6
Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland6
Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer6
177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer6
Predictive factors for prolonged sick leave in breast cancer patients treated with adjuvant therapies: a retrospective registry study6
Consistency in contouring of organs at risk by artificial intelligence vs oncologists in head and neck cancer patients6
Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab6
Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition6
Patient-reported lower limb edema after primary radiotherapy for prostate cancer6
Sexual functioning, sexual enjoyment, and body image in Norwegian breast cancer survivors: a 12-year longitudinal follow-up study and comparison with the general female population6
Familial features affecting the melanoma risk in CDKN2A -negative melanoma families: a study based on the Swedish Cancer Registry6
Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes – a cross-sectional study6
Turning the page on 2024 – embracing Open Science6
The effect of psychosocial interventions for sexual health in patients with pelvic cancer: a systematic review and meta-analysis6
A comparative analysis of fear of cancer recurrence in patients with small renal masses: Active surveillance versus cryoablation6
Recent incidence trends of oesophago-gastric cancer in Sweden6
Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise6
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors6
Cervical, liver and stomach cancer incidence and mortality in non-Western immigrant women: a retrospective cohort study from four Nordic countries6
High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings6
Clinical outcomes of ALK + non-small cell lung cancer in Denmark6
Progress against lung cancer, Denmark, 2008–20226
Effectiveness of physiotherapy interventions on improving quality of life, total neuropathy score, strength and reducing pain in cancer survivors suffering from chemotherapy-induced peripheral neuropa6
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy6
Combination therapy with immune check point inhibitors and acute kidney injury5
Liver cancer risk quantification through an artificial neural network based on personal health data5
Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer5
Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature5
Spot-scanning proton therapy for early breast cancer in free breathing versus deep inspiration breath-hold5
Treatment-related mortality in childhood cancer patients – who, when and how much5
Area-based disparities in non-small-cell lung cancer survival5
Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy5
Correction5
Increased cancer incidence among patients with hidradenitis suppurativa – a Danish nationwide register study 1977–20175
Involving adolescents and young adults (AYA) with an uncertain or poor cancer prognosis as research partners5
The impact of implementing current treatment modalities and female sex on gastric cancer outcomes, 2000–2016: a longitudinal nationwide cohort study5
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study5
Significant risk of second primary cancer among laryngeal squamous cell carcinoma patients even after 20 years5
The association between education and fear of recurrence among breast cancer patients in follow-up – and the mediating effect of self-efficacy5
Patterns of care in oligometastatic disease: the clinicians’ perspective5
Real-life experience with sorafenib for advanced and refractory desmoid-type fibromatosis5
Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study5
Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy5
Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study5
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study5
Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study5
Cost-effectiveness of different exercise intensities during oncological treatment in the Phys-Can RCT5
Is it okay to choose to receive bad news by telephone? An observational study on psychosocial consequences of diagnostic workup for lung cancer suspicion5
Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival – a Swedish Lymphoma Register Study5
Who are the vulnerable lung cancer patients at risk for not receiving first-line curative or palliative treatment?5
Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide5
Improving knowledge-based treatment planning for lung cancer radiotherapy with automatic multi-criteria optimized training plans5
Radiation dose to sleep-relevant brain structures linked to impaired sleep quality in primary brain tumor patients5
Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?5
Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma5
Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients5
Accuracy of Essential TNM to stage large colorectal (T3/T4) cancers in absence of nodal status information5
Health-related quality of life, needs, and concerns among cancer survivors referred to rehabilitation in primary healthcare setting5
Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial5
Trends in cost of treatment of lung cancer patients in 2014–2019 in Finland – a descriptive register study5
Development and validation of an [18F]FDG-PET/CT radiomic model for predicting progression-free survival for patients with stage II – III thoracic esophageal squamous cell carcinoma who are5
Prospective evaluation of bowel function and quality of life after colon cancer surgery – is it time for routine screening for late sequelae?5
Robustness of multifield pseudo-arc proton therapy for sinonasal cancer5
Parenting under pressure: a cross-sectional questionnaire study of psychological distress, parenting concerns, self-efficacy, and emotion regulation in parents with cancer5
The BioLymph study – implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results5
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study5
Survival with lung cancer in Finland has not improved during 2007–2019–a single center retrospective population-based real-world study5
Circulating DNA in the neoadjuvant setting of early stage colon cancer5
Locoregional breast radiotherapy including IMN: optimizing the dose distribution using an automated non-coplanar VMAT-technique5
Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study5
The gold standard program (GSP) for smoking cessation: a cohort study of its effectiveness among smokers with and without cancer5
Predictors of preparedness for recovery following colorectal cancer surgery: a latent class trajectory analysis5
Differences in adjuvant chemotherapy and oncological outcomes according to margin status in patients with stage III colon cancer5
Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease5
Pregnancy outcomes in female survivors of neuroblastoma: a short report from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study5
A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes4
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial4
Days alive and out of hospital following primary surgery for oral cavity squamous cell carcinoma4
TNM stage in the Nordic Cancer Registries 2004–2016: Registration and availability4
The Abbey Pain Scale: not sufficiently valid or reliable for assessing pain in patients with advanced cancer4
Fear of cancer recurrence eight years after early-stage breast cancer – results from a national survey4
Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature4
Using immunotherapy to enhance the response of a C3H mammary carcinoma to proton radiation4
Do investments in cancer registry databases and tools bring added value? NORDCAN as an example4
Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study4
Electrochemotherapy with intravenous bleomycin for patients with cutaneous malignancies, across tumour histology: a systematic review4
Second primary cancer following primary oral squamous cell carcinoma: a population-based, retrospective study4
Is stereotactic body radiotherapy an effective treatment in metastatic lung cancer with oligoprogressive disease?4
High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the Body & Cancer cohort4
The clinical value of C-reactive protein and its association with tumour location in patients undergoing curative surgery for colorectal cancer – a ScotScan collaborative study4
The impact of a multi-hospital network on the inequality in odds of receiving resection or ablation for synchronous colorectal liver metastases4
Metabolic parameters of [18F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer4
Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study4
Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis4
Striving to excel – effects from vacation periods on cancer incidence and outcome4
Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer4
Effects on long-term survival of psychosocial group intervention in early-stage breast cancer: follow-up of a randomized controlled trial4
First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy4
Implementing MyChoice® CDx HRD testing for the Nordics: lessons from 2021 to 20234
The current role of local treatment in metastatic prostate cancer: systematic review and meta-analysis4
Bowel dysfunction following pelvic organ cancer: a prospective study on the treatment effect in nurse-led late sequelae clinics4
A retrospective, non-interventional study of breast cancer patients diagnosed with ER+/HER2 negative, locally advanced or metastatic breast cancer treated with palbociclib in Denmark4
Penile cancer: long-term infectious and thromboembolic complications following lymph node dissection – a population-based study (Sweden)4
Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study4
Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin4
Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial4
Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study4
Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study4
Childhood cancer incidence and survival in the Faroe Islands, 1960 to 20194
Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice4
Radiotherapy respiratory motion management in hepatobiliary and pancreatic malignancies: a systematic review of patient factors influencing effectiveness of motion reduction with abdominal compression4
Association between anxiety and depression symptoms and completion of first-line treatment in newly diagnosed lung cancer patients4
Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer4
End-of-life care of patients with esophageal or gastric cancer: decision making and the goal of care4
Prospective surveillance for breast cancer-related lymphedema (PROTECT)4
0.09520697593689